PanCan Diagnosed (a miRNA Approach): Using Feature Selection, Ensemble Algorithms, and Interpretability for the Early Diagnosis and Personalized Medicine of Pancreatic Cancer
ISEF · 2021 Robotics and Intelligent Machines Fourth Award
Overview
The early diagnostic rate of pancreatic cancer (PC) is currently at just 9% as screening methods are unattainable, making it the fourth leading cause of cancer death. Many studies have achieved low accuracy (70-75%) as they use methods that do not take into account the 33% misdiagnosis rate of PC with other cancers. As a result, feature selection, ensemble algorithms, and interpretability techniques were used to find significant miRNAs, or biomarkers, in order to construct an early diagnostic tool (PanCan Diagnosis) for PC. In the first phase, recursive feature elimination algorithms were used to find 200 differentially expressed miRNAs in PC and no PC samples as well as early and late PC samples. In the second phase, an ensemble algorithm was constructed from K-Nearest Neighbor, Naive Bayes, Neural Network, and Logistic Regression models in order to diagnose PC and distinguish between early and late stages. In the third phase, XGBoost, SHAP, and Skater interpretability methods were used to find most significant miRNAs in model predictions. In the fourth phase, a user interface, PanCan Diagnosis, was designed to test if a person had no, early, or late stage PC and also displayed the patient’s most differentially expressed miRNAs. This novel tool is the first in literature to receive a PC diagnostic accuracy of above 90%, seek miRNAs that can lead to personalized medicine of early and late stage PC samples, offers a ten-fold improvement in monetary costs, and is two times faster than current methods.
Awards (1)
- Fourth Award of $500 $500
Competition history
- ISEF 2021
Resources
Related projects
ISEF · 2020
PanCan Diagnosed: Developing an Algorithm for the Accurate and Affordable Early Diagnosis of Pancreatic Cancer via Machine Learning and Bioinformatics
ISEF · 2017
Detection of Premalignant Pancreatic Cancer via Computational Analysis of Serum Proteomic Profiles
ISEF · 2020
PANCREAS.AI: Novel Deep Learning-based Screening Towards Precision Applications for Pancreatic Cancer
ISEF · 2022
The Development of a Low-Cost Holistic System for the Stratified Screening of Pancreatic Ductal Adenocarcinoma Utilizing Urinary miRNA Biomarkers
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair